Strengthening the Bonds Between CMC and the Foundation
Our alumni based in the U.S. are the cornerstone of Vellore CMC Foundation’s efforts, providing us with invaluable support and innovative ideas. Our extraordinary alumni community exemplifies loyalty and dedication to CMC and to one another. They inspire and challenge all CMC graduates to act as a force for good in their community and globally.
Inspiring a Spirit of Healing and Innovation
CMC’s U.S. alumni are building their careers in American medical institutions by delivering care with empathy, contributing to scientific breakthroughs, and sharing their knowledge with the next generation of healthcare professionals. Their commitment to medical excellence and high-quality care are a testament to the quality of their education at CMC Vellore.
CMC Alumni Making News and History
Dr. Nalini Vadivelu (‘70), Professor of Anesthesiology at Yale University, recently invented a special laryngeal mask with inbuilt suction to enable easy access to the hypopharynx in order to remove secretions from the nose and mouth.
Dr. Honarine Ward (‘69), Professor of Medicine at Tufts University, in collaboration with international investigators, is conducting cross sectional and longitudinal studies of infectious diarrheal diseases, particularly among children in resource-limited settings.
CMC Alumni in the News
Dr. Gagandeep Kang (Batch ’81) Participated in the India-US Health Partnership roundtable on “Vaccine for All”
The Indian Embassy in the United States organized a roundtable on “Vaccine for All” as part of the India-US Health Partnership. The event was conducted virtually in February 2022. The Ambassador of India to the United States, Taranjit Singh Sandhu attended the conference along with Bill
New Jersey’s Only NCI-designated Comprehensive Cancer Center Names Director for Phase I Clinical Trials and Investigational Therapeutics
Enhancing its commitment to providing the most advanced treatment options for cancer patients through clinical trials, Rutgers Cancer Institute of New Jersey has named Sanjay Goel, MD, MS as director of its Phase I/Investigational Therapeutics Program. He is also a professor of medicine at Rutgers Robert Wood
Dr. Alok Srivastava Presents a Promising Experimental Hemophilia Therapy at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition
Fitusiran, an experimental hemophilia therapy administered through a monthly subcutaneous injection, met its primary endpoint in a phase III trial being presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. The drug dramatically reduced bleeding events, with half of those receiving
Dr. Priya Abraham, director of the National Institute of Virology, profiled in Forbes India. As the head of the National Institute of Virology, her team came across the first sample of Covid-19 in India and isolated the SARS-Cov-2 virus. Read Abraham’s perspective on how virology